Cabergoline Tablet
Product Images NDC 27808-315

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 27808-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cranbury Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (16b9bafe 8cb2 4106 Adeb 27d210fc85e4 01)

Chemical structure of cabergoline depicting its molecular framework with rings and side chains, consistent with its identity as the active ingredient in the drug cabergoline.*

FDA Label Image

Bottle Label 0.5 mg (16b9bafe 8cb2 4106 Adeb 27d210fc85e4 02)

Label for Cabergoline Tablets, USP 0.5 mg oral tablets. The carton contains 8 tablets. Manufactured by Renata PLC, Bangladesh, and labeled for Cranbury Pharmaceuticals, LLC. Label includes storage instructions, dosage advisories, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.